Cargando…
WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS
Autores principales: | KLOCHKOVA, N., Lysenko, M., Zeltyn-Abramov, E., Poteshkina, N., Markova, T., Frolova, N., Belavina, N., Kondrashkina, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025623/ http://dx.doi.org/10.1016/j.ekir.2023.02.1001 |
Ejemplares similares
-
POS-628 THE IMPACT OF OBESITY ON ADVERSE OUTCOME OF COVID-19 IN PATIENTS ON MAINTENANCE HEMODIALYSIS DUE TO DIABETIC KIDNEY DISEASE
por: Zeltyn-Abramov M., E., et al.
Publicado: (2021) -
WCN23-1238 COMORBIDITIES ASSOCIATED WITH INCREASED RISK OF DEATH IN CKD PATIENTS WITH COVID-19
por: BRAZ, B., et al.
Publicado: (2023) -
WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
por: Stepanova MD, N., et al.
Publicado: (2023) -
WCN23-0886 CONTRIBUTION TO THE STUDY OF ADVERSE EVENTS FOLLOWING VACCINATION AGAINST COVID-19 IN CHRONIC HEMODIALYSIS PATIENTS IN SENEGAL: A REVIEW OF 367 CASES
por: SARR, I., et al.
Publicado: (2023) -
WCN23-0981 RISK FACTORS FOR COVID-19 MORTALITY IN HEMODIALYSIS PATIENTS
por: TOMANOSKI, V., et al.
Publicado: (2023)